Apurv Agrawal, MD

New Jersey Hematology Oncology Associates
Brick, NJ
USA Papers:
1387 Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)
4306 Disease and Clinical Characteristics of Patients with Essential Thrombocythemia Enrolled in the MOST Study